Evidence map›Paper›PMID 20363917›Full record

ArticleThe American journal of pathology2010

Characterization of a model of an arteriovenous fistula in the rat: the effect of L-NAME.

Anthony J Croatt, Joseph P Grande, Melissa C Hernandez, Allan W Ackerman, Zvonimir S Katusic, Karl A Nath

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 56 citations in OpenAlex.

  1. Review
  2. A Vein Attempt? Experimental Models for Arteriovenous Fistula Research.Cardiovascular engineering and technology · 2026
    Review
  3. The rodent models of arteriovenous fistula.Frontiers in cardiovascular medicine · 2024
    Review
  4. A Murine Model of Hemodialysis Access-related Hand Dysfunction.Journal of visualized experiments : JoVE · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Predicting the Functionality and Form of a Dialysis Fistula.Journal of the American Society of Nephrology : JASN · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anthony J CroattDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota 55905, USA.
Joseph P Grande
Melissa C Hernandez
Allan W Ackerman
Zvonimir S Katusic
Karl A Nath
Mayo Clinic · USTherapeutics Clinical Research · US

Funding

Renal Injury and Adaptation to Heme ProteinsR37DK047060 · NIDDK · MAYO CLINIC ROCHESTER · PI NATH, KARL A. · 2002 to 2011
$3.6M
Mechanism of Dialysis Arteriovenous Fistula DysfunctionR01DK070124 · NIDDK · MAYO CLINIC ROCHESTER · PI NATH, KARL A. · 2005 to 2015
$3.4M
RENAL INJURY AND ADAPTATION TO HEME PROTEINSR01DK047060 · NIDDK · UNIVERSITY OF MINNESOTA TWIN CITIES · PI NATH, KARL A. · 1993 to 2018
$2.2M
NIDDK NIH HHS DK 47060NIDDK NIH HHS DK 70124NIDDK NIH HHS R01 DK047060NIDDK NIH HHS R01 DK070124NIDDK NIH HHS R37 DK047060
6 · The paper itself

Abstract

Vascular access dysfunction contributes to the mortality of patients undergoing chronic hemodialysis. The present study analyzed the changes that evolve in a femoral arteriovenous fistula in the rat. The venous segment of this model exhibited, at 1 week, activation of pro-inflammatory transcription factors and up-regulation of pro-inflammatory, proliferative, procoagulant, and profibrotic genes; and at 4 weeks, the venous segment displayed neointimal hyperplasia, smooth muscle proliferation, and thrombus formation. These changes were accompanied by endothelial (e) nitric oxide synthase (NOS) and inducible (i) NOS up-regulation. The administration of NG-nitro-L-arginine methyl ester, an inhibitor of NOS activity, increased venous neointimal hyperplasia and pro-inflammatory gene expression (monocyte chemoattractant protein-1 and cytokine-induced neutrophil chemoattractant-1), increased systolic blood pressure, and decreased blood flow through the fistula. In another hypertensive model, the rat subtotal nephrectomy model, venous neointimal hyperplasia in the arteriovenous fistula was also exacerbated. We conclude that this arteriovenous fistula model recapitulates the salient features observed in dysfunctional, hemodialysis arteriovenous fistulas, and that venous neointimal hyperplasia is exacerbated when this model is superimposed in two different models of systemic hypertension. Since the uremic milieu contains increased amounts of asymmetric dimethylarginine, we speculate that such accumulation of this endogenous inhibitor of NOS, by virtue of its pressor or nitric oxide-depleting effects, or a combination thereof, may contribute to the limited longevity of arteriovenous fistulas used for hemodialysis.

Indexed as

Gene Expression RegulationAnimalsArteriovenous FistulaDisease Models, AnimalEnzyme InhibitorsInflammationModels, BiologicalMyocytes, Smooth MuscleNG-Nitroarginine Methyl EsterNitric OxideRatsRats, Sprague-DawleyRenal DialysisReverse Transcriptase Polymerase Chain ReactionThrombosisEnzyme InhibitorsNG-Nitroarginine Methyl EsterNitric Oxide

Identifiers

PMID20363917
PMCPMC2861117
OpenAlexW129580362

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.